
At the recent EACD and IAACD 2025 Congress, the message was loud and clear: early detection and early intervention are no longer optional, they are essential.
In session after session, researchers, clinicians, and community leaders pushed for screening before one year and for therapy that begins in the home.
Here’s why that matters, and what’s working in real-world low-resource settings.
Predicting CP Early with HINE and General Movements
The Hammersmith Infant Neurological Examination (HINE) and General Movements Assessment (GMA) can flag cerebral palsy risk within the first few months of life.
GMA evaluates spontaneous movement in infants, and the absence of "fidgety movements" around 12–16 weeks is a strong predictor.
HINE, used between 12 and 40 weeks, offers a simple neurological assessment linked to future function.
In this trial in West Bengal, India, researchers used both HINE and GMA to identify infants at high risk of CP. These babies then received an intervention called LEAP‑CP, showing strong outcomes in mobility, cognition, and maternal wellbeing by 18 months.

What LEAP‑CP Actually Does
LEAP‑CP (Learning through Everyday Activities with Parents) is a home-based, peer-delivered intervention for infants at risk of CP.
It focuses on play-based motor goals, cognitive learning, visual engagement, and carer mental health.
Around 15–30 home visits are delivered by trained community peers, not specialists.
Sessions are designed to work around daily routines and use items already in the home.
The LEAP-CP India study found statistically significant improvements in Peabody Motor scores (PDMS-2), cognitive goal achievement, and reduced stress for mothers. This model makes therapy accessible, frequent, and meaningful.
First Nations Adaptation: LEAP‑CP in Australia
In Australia, the LEAP‑CP Indigenous project adapted the program for Aboriginal and Torres Strait Islander communities, who face up to 50% higher CP rates and severe gaps in service access.
Cultural advisors shaped content and delivery to respect language, values, and beliefs.
First Nations Health Workers were trained to conduct screening (HINE, GMA) and deliver LEAP-CP over 30 visits.
The model prioritised trust, flexibility, and family partnership.
This culturally responsive delivery increased access to early rehab for babies who might otherwise miss the neuroplasticity window.

What We Heard at the Congress
At EACD–IAACD, many presenters backed early motor assessments:
HINE, GMA, and the Gross Motor Function Classification System (GMFCS) were widely used in real-world trials.
Gross Motor Function Measure (GMFM) was the tool of choice for tracking functional gains over time.
Researchers pushed for early detection and therapy before 12 months, especially in underserved areas.
The goal? To act during peak neuroplasticity and give infants the best start possible.
What You Can Do Now
1. Train frontline staff in early screening using HINE and GMA.
2. Adapt LEAP‑CP or similar models to your cultural or geographic setting.
3. Work with peer trainers or community workers, not just health professionals.
4. Track outcomes using tools like GMFM, PDMS-2, and parent reports.
5. Start before diagnosis. Do not wait until two years.
Why This Matters
Too often, children with CP are diagnosed late, missing a crucial window for intervention. LEAP‑CP, HINE, and GMA together offer a pathway for early action, even in rural, Indigenous, or low-resource communities.
These models are proven, accessible, and ready to be used, not just researched.
Could you bring LEAP‑CP or early screening into your own setting? The evidence is there. The tools are ready. The time to act is early.
Let’s not wait to move. Let’s move early, where it matters most.